sulfadiazine has been researched along with Focal Neurologic Deficits in 2 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Townsend, JJ | 1 |
| Wolinsky, JS | 1 |
| Baringer, JR | 1 |
| Johnson, PC | 1 |
| Doyle, EF | 1 |
| Spagnuolo, M | 1 |
| Taranta, A | 1 |
| Kuttner, AG | 1 |
| Markowitz, M | 1 |
2 other studies available for sulfadiazine and Focal Neurologic Deficits
| Article | Year |
|---|---|
Acquired toxoplasmosis. A neglected cause of treatable nervous system disease.
Topics: Adult; Bronchopneumonia; Clinical Laboratory Techniques; Female; Fluorescent Antibody Technique; Hod | 1975 |
The risk of bacterial endocarditis during antirheumatic prophylaxis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Endocarditis, Bacterial; Female; Humans; Joint Dise | 1967 |